Zenas BioPharma (ZBIO) Prepaid Assets (2023 - 2026)

Zenas BioPharma's Prepaid Assets history runs 4 years deep, the most recent figure standing at $13.0 million for Q1 2026.

• On a quarterly basis, Prepaid Assets rose 138.74% year-over-year to $13.0 million in Q1 2026; TTM through Mar 2026 was $13.0 million, a 138.74% increase from a year earlier, with the FY2025 full-year figure at $8.0 million, up 57.47% from the prior year.
• Prepaid Assets grew to $13.0 million in Q1 2026 per ZBIO's latest filing, from $8.0 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $13.0 million in Q1 2026 and bottomed at $2.9 million in Q4 2023.
• The 4-year median for Prepaid Assets is $5.6 million (2025), against an average of $6.6 million.
• Across the five-year window, Prepaid Assets dropped 17.5% in 2025 and jumped 138.74% in 2026, its largest moves.
• Year by year, Prepaid Assets stood at $2.9 million in 2023, then soared by 71.94% to $5.1 million in 2024, then jumped by 57.47% to $8.0 million in 2025, then jumped by 62.41% to $13.0 million in 2026.
• Per Business Quant, the three latest ZBIO Prepaid Assets figures stand at $13.0 million (Q1 2026), $8.0 million (Q4 2025), and $5.8 million (Q3 2025).